HIV Association Autumn meeting - Provisional programme
Saturday 9 October 1999
Any treatment regimen used after a number of earlier regimens have failed. People with HIV who have experienced side-effects and/or developed resistance to many HIV drugs receive salvage therapy, sometimes consisting of a large number of medications.
The transition period from infection with HIV to the detectable presence of HIV antibodies in the blood. When seroconversion occurs (usually within a few weeks of infection), the result of an HIV antibody test changes from HIV negative to HIV positive. Seroconversion may be accompanied with flu-like symptoms.
A study design in which patients receive routine clinical care and researchers record the outcome. Observational studies can provide useful information but are considered less reliable than experimental studies such as randomised controlled trials. Some examples of observational studies are cohort studies and case-control studies.
The very first few weeks of infection, until the body has created antibodies against the infection. During acute HIV infection, HIV is highly infectious because the virus is multiplying at a very rapid rate. The symptoms of acute HIV infection can include fever, rash, chills, headache, fatigue, nausea, diarrhoea, sore throat, night sweats, appetite loss, mouth ulcers, swollen lymph nodes, muscle and joint aches – all of them symptoms of an acute inflammation (immune reaction).
From 0800 hours BHIVA Registration and coffee
0900 -1015 Glaxo Wellcome Satellite Symposium: HIV disease management in the next millennium
1015 -1045 Coffee and refreshments
1045 -1100 Welcome address, followed by The role of consensus guidelines - Prof Brian Gazzard
1100 -1125 The role of observational studies - Prof Andrew Phillips
When to start therapy?
1125 -1155 Seroconversion: to treat or not to treat acute HIV infection Prof Bruce Walker
1155 -1210 Interactive audience discussion
What to start with?
1210 -1240 BHIVA Foundation Lecture: Let hundreds of flowers bloom - Prof Joep Lange
1240 -1255 Interactive audience discussion
1300 -1415 Lunch
When to change?
1415 -1445 How to change therapy based on resistance - Prof Charles Boucher
1445 -1500 Adherence/drug levels - Dr John Walsh
What to change to?
1500 -1515 Salvage therapy - Prof Brian Gazzard
1515 -1545 Interactive audience discussion
1545 -1615 Afternoon tea
1615 - 1645 BHIVA AGM(members only)
1700 Cocktail reception